Sunshine Biopharma Inc. (SBFM) Return on equity 2021–2025
Sunshine Biopharma Inc. (SBFM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-25.9%FY2025 · since FY2021: -5875.6% → -25.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -25.9% | -4.1 pp |
| FY2024 | -21.8% | -0.6 pp |
| FY2023 | -21.2% | +102.4 pp |
| FY2022 | -123.7% | +5752.0 pp |
| FY2021 | -5875.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →